Kidney & Blood Pressure Research · 2007 · 14 citations · 30 references
MedicineNephrologyPathologyImmunopathologyRenal PathologyRenal PathophysiologyGlomerular PathophysiologyRenal DiseaseRenal FibrosisRenal ImmunopathologyRenal InflammationTubulointerstitial DiseasesGlomerular Capillary DamageMonocyte Chemoattractant Protein-1Proteinuria CorrelationRenal Biopsy DiagnosisRenal Biopsy FindingsRenal Inflammatory InjuryTubulointerstitial Damage BiomarkersTubulointerstitial Injury Biomarkers
BACKGROUND/AIMS: The urinary concentration of the monocyte chemoattractant protein-1 (uMCP-1) chemokine is increased in several proteinuric and/or inflammatory renal diseases. In the present study, we evaluated the association between uMCP-1 and renal function, proteinuria, glomerular and interstitial macrophage infiltration, and renal fibrosis in patients with primary and secondary glomerulopathies diagnosed by renal biopsy. METHODS: Thirty-seven patients aged 32.6 +/- 7.7 years were studied. uMCP-1 was determined by ELISA. Renal macrophage expression (CD68 positive cells) is reported as number of macrophages/10(4) microm2 of the cortical tubulointerstitial (TI) area or of glomerular capillary tuft area. Cortical interstitial fibrosis was quantitated by PicroSirius red staining under polarized light by a computerized manner. RESULTS: The uMCP-1 ratio (pg/ml/urinary creatinine mg/ml) was positively correlated (Spearman coefficient) with proteinuria (r = 0.4629; p < 0.005) and number of macrophages in the cortical TI area (r = 0.64; p = 0.0005), and negatively correlated with creatinine clearance (r = -0.4877; p < 0.001). The uMCP-1 ratio was not significantly correlated with number of macrophages/glomerular capillary tuft area (r = 0.27; p = 0.19) or with percent cortical interstitial fibrosis (r = 0.08; p = 0.62). CONCLUSIONS: The uMCP-1 excretion is a biomarker of the inflammatory activity of the TI area, and does not reflect chronic interstitial damage.
30
Clare M. Lloyd, Andrew W. Minto, Martin E. Dorf et al. · The Journal of Experimental Medicine · 1997 · 496 citations · Full text
Medicine, Immunology, Pathology +17
Allison A. Eddy, Cecilia M. Giachelli, with the technical assistance of Lorinda McCulloch et al. · Kidney International · 1995 · 366 citations
Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney
Kiyoki Kitagawa, Takashi Wada, Kengo Furuichi et al. · American Journal Of Pathology · 2004 · 336 citations · Full text
Medicine, Immunology, Nephrology +12